Omega Healthcare Investors (NYSE:OHI) PT Raised to $45.00 at BMO Capital Markets

Omega Healthcare Investors (NYSE:OHI) had its target price increased by investment analysts at BMO Capital Markets from $44.00 to $45.00 in a report issued on Monday, Benzinga reports. The firm currently has a “market perform” rating on the real estate investment trust’s stock. BMO Capital Markets’ price target suggests a potential upside of 13.91% from the company’s previous close.

Several other analysts have also commented on the company. Scotiabank boosted their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research note on Monday, August 26th. Truist Financial lifted their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Finally, Mizuho cut shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their target price for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th. Eight analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Omega Healthcare Investors currently has an average rating of “Hold” and a consensus target price of $37.00.

Omega Healthcare Investors Price Performance

NYSE:OHI opened at $39.51 on Monday. The company has a debt-to-equity ratio of 1.19, a quick ratio of 5.79 and a current ratio of 5.79. The company has a 50-day moving average of $39.16 and a 200-day moving average of $34.72. Omega Healthcare Investors has a 52 week low of $27.53 and a 52 week high of $41.53. The company has a market capitalization of $9.76 billion, a price-to-earnings ratio of 35.59, a PEG ratio of 1.29 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). The business had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The business’s revenue for the quarter was up 17.5% on a year-over-year basis. During the same period last year, the company earned $0.74 EPS. As a group, equities research analysts anticipate that Omega Healthcare Investors will post 2.69 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at $4,025,000. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Hedge Funds Weigh In On Omega Healthcare Investors

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Hennion & Walsh Asset Management Inc. increased its stake in shares of Omega Healthcare Investors by 96.7% during the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 21,799 shares of the real estate investment trust’s stock worth $690,000 after purchasing an additional 10,714 shares during the last quarter. Slagle Financial LLC boosted its stake in shares of Omega Healthcare Investors by 102.1% during the fourth quarter. Slagle Financial LLC now owns 94,586 shares of the real estate investment trust’s stock valued at $2,900,000 after purchasing an additional 47,785 shares in the last quarter. Private Advisor Group LLC grew its holdings in Omega Healthcare Investors by 6.6% during the 1st quarter. Private Advisor Group LLC now owns 28,772 shares of the real estate investment trust’s stock worth $911,000 after acquiring an additional 1,783 shares during the last quarter. Park Avenue Securities LLC increased its holdings in Omega Healthcare Investors by 5.7% in the first quarter. Park Avenue Securities LLC now owns 10,066 shares of the real estate investment trust’s stock valued at $319,000 after purchasing an additional 544 shares during the period. Finally, HighPoint Advisor Group LLC acquired a new stake in shares of Omega Healthcare Investors in the fourth quarter valued at about $758,000. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.